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Stroke is one of the most complex diseases, with several subtypes, as well as secondary risk factors, such as
hypertension, hyperlipidemia, and diabetes, which, in turn, have genetic and environmental risk factors of their
own. Here, we report the results of a genomewide search for susceptibility genes for the common forms of stroke.
We cross-matched a population-based list of patients with stroke in Icelandwith an extensive computerizedgenealogy
database clustering 476 patients with stroke within 179 extended pedigrees. Linkage to 5q12 was detected, and
the LOD score at this locus meets the criteria for genomewide significance (multipoint allele-sharing LOD score of
4.40, ). A 20-cM region on 5q was physically and genetically mapped to obtain accurate marker56Pp 3.9 # 10
order and intermarker distances. This locus on 5q12, which we have designated as “STRK1,” does not correspond
to known susceptibility loci for stroke or for its risk factors and represents the first mapping of a locus for common
stroke.
Introduction
Stroke is a major health problem in western societies. It
is the most common cause of disability, the second-most-
common cause of dementia, and the third-most-common
cause of death (Bonita 1992). Since it is more common
in the elderly, the public health impact of stroke will
increase in the next decades with growing life expec-
tancy. Approximately one in four men and one in five
women aged 45 years will have a stroke if they live to
their 85th year (Bonita 1992). Strategies to diminish the
impact of stroke include prevention and treatment with
thrombolytic and, possibly, neuroprotective agents. The
success of preventive measures will depend on the iden-
tification of risk factors and means to modulate their
impact.
The clinical phenotype of stroke is complex but
can be broadly divided into ischemic and hemor-
rhagic strokes. The majority (80%–90%) of strokes
are ischemic—that is, they are caused by obstruction
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of blood flow through extra- or intracranial vessels
(Mohr et al. 1978; Caplan 2000). The remainder
(10%–20%) are hemorrhagic—that is, they result
from ruptures of intracranial vessels. Ischemic stroke
can be further subdivided into large-vessel occlusive
disease, small-vessel occlusive disease, and cardio-
genic stroke. For the purposes of this study, we have
included transient ischemic attack (TIA) as a biolog-
ical equivalent of ischemic stroke, even though TIA
is not defined as a stroke (because the signs and symp-
toms, which are the same as those for stroke, last for
a short period of time [i.e., !24 h; usually 5–10 min]).
This is done because the same pathophysiological
mechanisms are considered responsible for TIA and
ischemic stroke (Caplan 2000).
The predominant risk factor for all types of stroke is
hypertension (Thompson and Furlan 1997; Agnarsson
et al. 1999). Hypertension is in itself a complex disease,
as are the other known risk factors, diabetes and hy-
perlipidemia. In addition, there are environmental risk
factors, such as smoking. Stroke is therefore considered
to be a highly complex disease consisting of a group of
heterogeneous disorders with multiple risk factors, both
genetic and environmental.
The identification of genetic determinants of common
diseases, such as stroke, that may result from the in-
terplay of multiple genes and interactions between genes
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and environment has proven to be a difficult task. Stud-
ies of the genetic contribution to stroke have mainly
focused either on rare Mendelian diseases in which
stroke is a part of the phenotype or on finding associ-
ation between stroke and possible candidate genes, such
as genes contributing to hypertension or lipid metab-
olism. Several genes have been identified that play roles
in the pathogenesis of rare stroke syndromes, such as
Notch3, in cerebral autosomal dominant arteriopathy
with subcortical infarctions and leukoencephalopathy
(Tournier-Lasserve et al. 1993; Joutel et al. 1996); Cys-
tatin C, in the Icelandic type of hereditary cerebral hem-
orrhage with amyloidosis (Palsdottir et al. 1988); APP,
in the Dutch type of hereditary cerebral hemorrhage
(Levy et al. 1990); and KRIT1, in hereditary cavernous
angioma (Gunel et al. 1995; Laberge-le Couteulx et al.
1999; Sahoo et al. 1999).
To our knowledge, no genomewide search for
stroke genes in patients with the common forms of
stroke has ever been reported. Here we report the
results of a genomewide search for susceptibility
genes in common stroke by use of a broad but rig-
orous definition of the phenotype, including hemor-
rhagic stroke, ischemic stroke, and TIA. The result
of this is the mapping of the first major locus reported
in common stroke.
Subjects and Methods
Patients
An encrypted population-based list that contained
2,000 living Icelandic patients with stroke and was based
on hospital International Classification of Diseases, Ninth
Revision codes covering the period of time from 1993
to 1997 was run through our computerized genealogy
database (Gulcher and Stefansson 1998; Gulcher et al.
2000), which covers the whole Icelandic nation. We ex-
cluded patients with subarachnoid hemorrhage or the
Icelandic type of hereditary cerebral hemorrhage with
amyloidosis. The distribution of stroke types in our
study is similar to that reported in other white popu-
lations, with ∼67% having ischemic strokes, 27% hav-
ing TIAs, and 6% having hemorrhagic strokes (Caplan
2000). All patients underwent computerized tomogra-
phy of the head, and the majority of patients underwent
Doppler ultrasound of carotid arteries and echocardio-
graphy; Holter monitoring was frequently used.
We collected patients with stroke and/or TIAs by use
of the criterion that the relationship between each pa-
tient and at least one additional patient was character-
ized by no more than six meiotic events (six meiotic
events separate second cousins). Participating patients
were more carefully phenotyped by the clinicians before
their genotypes were generated. Patients with ischemic
stroke and TIAs were classified according to the TOAST
(Trial of Org 10172 in Acute Stroke Treatment) sub-
classification system (Adams et al. 1993). This system
includes five categories: (1) large-artery atherosclerosis,
(2) cardioembolism, (3) small-artery occlusion (lacune),
(4) stroke of other determined etiology, and (5) stroke
of undetermined etiology. The diagnoses were based on
clinical features and on data from ancillary diagnostic
studies. Patients classified as having large-artery ather-
osclerosis had clinical and brain-imaging findings of ce-
rebral cortical dysfunction and either significant (170%)
stenosis (this is a stricter criteria than that used in
TOAST, in which 50% stenosis is the cutoff) or occlu-
sion of a major brain artery or branch cortical artery.
Potential sources of cardiogenic embolism were ex-
cluded. The second category, cardioembolism, included
patients with at least one cardiac source for an embolus
and with potential large-artery sources of thromobosis
and embolism having been eliminated. Patients with
small-artery occlusion had one of the traditional clinical
lacunar syndromes and no evidence for cerebral cortical
dysfunction. A potential cardiac source of embolus and
stenosis 170% in an ipsilateral extracranial artery was
excluded. The fourth category, acute stroke of other de-
termined etiology, included patients with rare causes of
stroke and patients with two or more potential causes
of stroke. If the causes of stroke could not be determined
despite extensive evaluation, then patients were included
in the fifth category, stroke of undetermined etiology.
TOAST classification of patients with ischemic stroke
and TIA whom we studied is presented in table 1. Apart
from the proportion of large-vessel disease, which is
lower in the population that we studied, the subtype
distribution is similar to those reported in other studies
(e.g., Caplan 2000). This is very likely due to the stricter
stenosis criterion that we used to classify large-vessel
disease.
The present study was approved by the Data Protec-
tion Commission of Iceland and the National Bioethics
Committee of Iceland. Informed consent was obtained
from all patients and their relatives whose DNA samples
were used in the linkage analysis.
Genomewide Scan
A genomewide scan was performed on 476 patients
and 438 of their relatives, by use of our framework
marker set of 1,000 microsatellite markers. We have de-
veloped a microsatellite screening set that is based, in
part, on the ABI Linkage Marker (version 2) screening
set and the ABI Linkage Marker (version 2) intercalating
set, in combination with 500 custom-made markers. All
markers were extensively tested for robustness, ease of
scoring, and efficiency in 4# multiplex PCRs. In our
framework marker set, the average spacing between
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Table 1
Subclassification of Patients with Stroke
SUBTYPE
% AFFECTED AMONG
All Patients
( )np 476
Patients in Families
with NPL 11
( )np 120
Hemorrhagic 5 6
Ischemic:
Large vessela 13 13
Small vessel 16 13
Cardioembolic 23 28
Other cause 4 5
More than one subtype or unknown cause 39 35
a The definition of ischemic large-vessel disease that we used is stricter than that usually
used in TOAST (see “Subject and Methods” section).
markers was ∼4 cM, with no gaps 110 cM. Marker
positions were obtained from the Marshfield map (Cen-
ter for Medical Genetics, Marshfield Medical Research
Foundation), except for the region containing a three-
marker putative inversion on chromosome 8 (Jonsdottir
et al. 2000; Giglio et al. 2001; Yu et al. 2001). The PCR
amplifications were prepared, run, and pooled on Perkin
Elmer/Applied Biosystems 877 Integrated Catalyst Ther-
mocyclers with a similar protocol for each marker. The
reaction volume was 5 ml, and, for each PCR, 20 ng of
genomic DNA was amplified in the presence of 2 pmol
of each primer, 0.25 U AmpliTaq Gold, 0.2 mM dNTPs,
and 2.5 mM MgCl2 (buffer was supplied by manufac-
turer). Cycling conditions were 95C for 10 min, fol-
lowed by 37 cycles at 94C for 15 s, annealing at 55C
for 30 s, and extension at 72C for 1 min. The PCR
products were supplemented with the internal size stan-
dard, and the pools were separated and detected on an
Applied Biosystems model 377 Sequencer by use of
Genescan version 3.0 peak-calling software. Alleles were
automatically called with the TrueAllele program (Cy-
bergenetics), and the DecodeGT program (deCODE Ge-
netics) was used both to fractionate according to quality
and to edit the called genotypes (Palsson et al. 1999).
At least 180 Icelandic controls were genotyped for each
marker to derive allele frequencies.
Statistical Methods for Linkage Analysis
In our analyses, we used multipoint, affected-only al-
lele-sharing methods to assess the evidence for linkage.
All results, including LOD and nonparametric linkage
(NPL) scores, were obtained using the program Allegro
(Gudbjartsson et al. 2000). We used the Spairs scoring
function (Whittemore and Halpern 1994; Kruglyak et
al. 1996) and the exponential allele-sharingmodel (Kong
and Cox 1997) to generate the relevant statistics with 1
df. When combining the family scores to obtain an over-
all score, instead of weighting the families equally (the
default of Genehunter [Kruglyak et al. 1996]) or weight-
ing the affected pairs equally, we used a weighting
scheme that is halfway between the two in the log scale;
the family weights that we used are the geometric means
of the weights of the two schemes. Although not iden-
tical, this weighting scheme tends to yield results that
are similar to those proposed by Weeks and Lange
(1988) as an extension of a weighting scheme by Hodge
(1984) that was designed for sibships. We computed the
P value two different ways and here report the less sig-
nificant result. The first P value was computed on the
basis of large sample theory; the distribution of Z plr
approximates a standard normal ran-2 [log (10)LOD]e
dom variable under the null hypothesis of no linkage
(Kong and Cox 1997). Because the normal approxi-
mation may not work well in some small-sample situ-
ations, we computed a second P value by comparing the
observed LOD score with its complete data-sampling
distribution under the null hypothesis (Gudbjartsson et
al. 2000). When a data set consists of more than a few
families, as is the case here, these two P values tend to
be very similar. To ensure that the result was a true
reflection of the information contained in the material,
we considered a linkage result significant not only if the
P value was (Lander and Kruglyak 1995)5! 2 # 10
but also if the information content in the region was
85%. For the families in the present study, an infor-
mation content of 85% corresponded to a marker den-
sity of approximately one marker per centimorgan. The
information measure we used has been defined elsewhere
(Nicolae 1999) and has been implemented in Allegro.
This measure is closely related to a classical measure of
information (Dempster et al. 1977), which has the prop-
erty that it is between zero, if the marker genotypes are
completely uninformative, and one, if the genotypes de-
termine the exact amount of allele sharing by descent
among the affected relatives.
After obtaining a significant allele-sharing LOD score,
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we attempted to understand the contribution of this sus-
ceptibility locus by fitting a range of parametric models
to the data. Even when fitting parametric models, we
performed affected-only analyses, in the sense that an
individual is classified as either affected or as having
unknown disease status. As a consequence, only ratios
of penetrances are relevant. We fitted a range of single-
locus dominant, additive, and multiplicative models
(Risch 1990). With a complex disease such as stroke,
none of these simple models are likely to be exactly true,
and the effect of a gene and its variants can only be
reliably determined after the at-risk variant (or variants)
is identified. However, by the calculation of the corre-
sponding contribution to the sibling recurrence-risk ra-
tio, the fitted parametric models do provide some rough
idea of how much the gene is contributing to the familial
clustering of the disease.
We investigated the contributions, to the identified lo-
cus, of several subtypes of and risk factors for stroke.
To do this, we utilized the complete family set and con-
sidered as affected only the patients with a particular
subtype of or risk factor for stroke. In one particular
case, to assess whether the LOD-score increase resulting
from the subtraction of the 22 patients with hemorrhagic
stroke would be likely to occur by chance, we selected
1,000 random sets of 22 patients whose status we then
changed to unknown in an analysis. The P value we
present is the fraction of the 1,000 simulations that pro-
duced, at the peak locus, a LOD-score increase that was
equal to or greater than that which we observed by
changing the affection status of the patients with hem-
orrhagic stroke to unknown.
Physical Mapping
To obtain correct marker order and sequence-ready
contigs, we physically mapped a 20-cM region, on 5q,
that was indicated in the genomewide scan. BAC contigs
were generated by a method that combines the results
of coincident primer-hybridization experiments with the
mining of publicly available sequences. RPCI-11 human
male BAC library segments 1 and 2 (Pieter de Jong,
Children’s Hospital Oakland Research Institute), con-
taining ∼200,000 clones with a 12# coverage of the
genome, were arrayed using a double-offset pat-6 # 6
tern on 23-cm # 23-cm membranes. Initially, hybridi-
zations were performed with markers that were ex-
pected, on the basis of their locations in the Weizmann
Institute of Science Unified Database for Human Ge-
nome Mapping, to be in the region of interest. We used
150 markers in the region (i.e., 31 polymorphic markers
used in linkage and 120 markers generated from se-
quence-tagged sites), which were separated by, on av-
erage, 130 kb. The selected markers were used to gen-
erate two [32P]-labeled probes: F, which contained the
pooled forward primers, and R, which contained the
pooled reverse primers. The coincident signals in both
hybridizations were selected as positive clones. A set of
overlapping clones was assembled through a combina-
tion of hybridization and BAC-fingerprint walking. Fin-
gerprints of positive clones (FPCs) were analyzed using
the FPC database developed at the Wellcome Trust San-
ger Institute. Data from FPC contigs prebuilt with a
cutoff of 3e12 and from sequence data mining were
integrated with the hybridization results. BACs in the
region detected by data mining and hybridization were
rearrayed. Small membranes (8 cm # 12 cm) were ar-
rayed in double-offset pattern and were individ-6 # 6
ually hybridized with the markers of interest. A visual
map was generated by combining the hybridization, fin-
gerprinting, and sequence data. A total of 137 new
markers were generated from BAC end sequences, and
the process was repeated until the majority of gaps were
closed. Estimates of contig lengths and of the distance
between markers assigned to them were based on the
FPC program.
Genetic Mapping
High-resolution genetic mapping was used to order
contigs obtained by physical mapping and to determine
their orientation. In addition to correct marker order,
the high-resolution genetic map also provided better es-
timates of intermarker distances, both of which are im-
portant for an accurate linkage analysis (Halpern and
Whittemore 1999; Daw et al. 2000). Data from 112
Icelandic nuclear families (sibships with genotypes for
two to seven siblings and both parents) were analyzed
together with the genotypes for nuclear families avail-
able within the stroke pedigrees. For the purpose of ge-
netic mapping, the 112 families alone provide 588 mei-
otic events, and the inclusion of the data from the
families with stroke yielded a map based on substantially
more than 1,000 meiotic events. By comparison, the
Marshfield genetic map (Center for Medical Genetics,
Marshfield Medical Research Foundation) was con-
structed on the basis of 182 meiotic events. The large
number of meiotic events within our families provides
the ability to map markers to a resolution 1.0 cM. In
evaluating one order of the markers versus another, by
modifying the Allegro program, we computed the num-
ber of obligate crossovers for each order, and the order
associated with a lower number of crossovers was pre-
ferred (Thompson 1987). Given an order, genetic dis-
tances between markers were estimated by implementing
the expectation-maximization algorithm (Dempster et
al. 1977) within the Allegro program. Combining the
information from genetic mapping with the physical
map resulted in a highly reliable order of markers and
intermarker distances within this 20-cM region.
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Figure 1 Four families with positive LOD scores. These families include patients with a variety of stroke subphenotypes, as defined by
TOAST subclassification (as labeled underneath shaded symbols). Squares and circles represent males and females, respectively; slash marks
through symbols indicate individuals who are deceased. Some sex indicators in the two upper generations of the pedigrees have been altered,
and unaffected siblings of patients are not displayed, to protect the confidentiality of these families.
Results
We collected samples from a total of 476 patients, each
of whom is related to (within and including six meiotic
events) at least one other patient. Patients with hem-
orrhagic stroke clustered in families with ischemic stroke
and TIA, and there were no families with a striking
preponderance of either hemorrhagic stroke or further
subtypes of ischemic stroke. Given this observation, we
decided to study stroke as a broadly defined phenotype.
The genome scan was performed with the 476 patients
clustered into 179 families. The mean separation of af-
fected pairs was 4.8 meiotic events. Figure 1, which dis-
plays four of the families, shows that several stroke sub-
types, including hemorrhagic stroke, are found mixed
together within the same pedigrees.
Figure 2 presents the allele-sharing LOD scores from
the genome scan by use of the framework map. Three
regions achieved a LOD score 11.0. Two of these regions
were on 5q: one peak at ∼69 cM, with a LOD score of
2.00, and a second peak at 99 cM, with a LOD score of
1.14. The third region is on 14q, at 55 cM, with a LOD
score of 1.24.
The information for analysis of linkage at the 5q locus
was increased by genotyping 45 additional markers over
a 45-cM segment that contains both of the regions on
5q (fig. 3). Although the LOD score at the second peak
decreased slightly, to ∼1.05, the LOD score at the first
peak increased to 3.39. However, close inspection of
our results suggested not only that the Marshfield ge-
netic map (Center for Medical Genetics, Marshfield
Medical Research Foundation) lacks resolution (i.e.,
many markers were assigned to the same location) but
also that there may be some errors in their order. When
we followed the marker order of the Marshfield map
and used the Allegro program and our data to estimate
Figure 2 Genomewide scan for stroke-susceptibility loci. A framework map of ∼1,000 markers was used. Each box represents a chromosome (indicated in the upper-right-hand corner of each
box). The X-axis gives the genetic distance (in cM), and the Y-axis gives the LOD scores.
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Figure 3 Dense mapping of stroke locus on chromosome 5, with
45 additional markers across the two peaks on 5q. The analysis used
the marker order of the Marshfield map (Center for Medical Genetics,
Marshfield Medical Research Foundation). The X-axis gives the ge-
netic distance (in cM) along the chromosome, and the Y-axis gives the
LOD score.
the genetic distances between markers, we found that
our estimate of the genetic length of the region was
substantially longer than that given in the Marshfield
map. This indicates a problem with marker order be-
cause, in general, incorrect marker order leads to an
increased number of apparent crossovers and increases
the apparent genetic length. We improved the marker
order and intermarker distances by constructing high-
density physical and genetic maps over a 20-cM region
between D5S474 and D5S2046 (fig. 4). It is worth not-
ing that, although our final order and intermarker dis-
tances deviate from those of Marshfield, the overall ge-
netic length for the region is similar.
Linkage analysis with genotypes from the higher-
density markers by use of our marker order resulted
in a LOD score of 4.40 ( ) on 5q12 at6Pp 3.9# 10
D5S2080. We designate this locus as “STRK1.” With
the addition of these extra markers, we were able to
narrow the most promising region for the harboring
of a stroke-susceptibility gene to a segment !6 cM,
from D5S1474 to D5S398, as defined by a decrease
of 1 in LOD score. Analyses with marker orders based
on publicly available marker maps yielded lower
LOD scores, 2.78–3.94, thereby highlighting the im-
portance of accurate marker order when using mul-
tipoint analysis (fig. 5).
In an attempt to understand the contribution of this
susceptibility locus to stroke, we fitted a range of para-
metric models to the data. The highest LOD score, 4.70,
was obtained from a multiplicative model under the
assumptions that the at-risk allele frequency was 27%
and that there was a fivefold increase in risk for every
at-risk allele carried. Under this model, the contribution
of this gene to the sibling recurrence-risk ratio was 1.86.
Seventy-five of the 179 family clusters yielded a positive
LOD score; of these, 55 had LOD scores 10.1, and 5
had LOD scores 10.4. The four families displayed in
figure 1 (i.e., families A–D) yielded LOD scores of 0.39,
0.40, 0.47, and 0.48, respectively. These results support
the existence of a major stroke-susceptibility gene in this
region.
The fractions of all patients in the study who have
the various subtypes of stroke are listed in table 1. The
fractions are also listed for those families with an NPL
score 11 (within these families, there is more sharing
among affected members of genetic material at the locus
than was expected owing simply to their relationship).
The families with more excess sharing at the locus do
not show any substantial difference in phenotype pat-
tern from the entire family set. Similar fractions are
presented for the risk factors for stroke in each of the
two family sets (table 2). Again, no substantial shift in
the prevalence of the risk factors is obvious. To assess
more directly the contribution of the various subtypes
and risk factors to the peak locus, linkage runs were
conducted in which only patients with the particular
subtype or risk factor were considered as affected—that
is, all other patients had their affection status changed
to unknown for these runs. In each of these runs, the
LOD scores were positive but were smaller than those
in the run including all patients. These decreases in
LOD score were consistent with the loss of power in
the smaller sample sizes. We also conducted a run in
which only patients with ischemic stroke were consid-
ered as affected. This run, which excluded the 22 pa-
tients with hemorrhagic stroke, had an increase in
LOD score. The allele-sharing LOD score for this run
increased to 4.86 at D5S2080. Although this 0.46 in-
crease in LOD score suggests that STRK1 is involved
primarily in ischemic strokes and TIAs, the increase
itself is not statistically significant, on the basis of sim-
ulations (one-sided ). In summary, these resultsPp .09
are consistent with a susceptibility gene at this locus
that contributes to a broad spectrum of patients with
stroke, the possible exception being patients with hem-
orrhagic stroke.
Discussion
In this study, we have successfully mapped a major locus
for one of the most complex diseases known, by com-
bining genealogy, a comprehensive population-based list
of patients with broadly defined stroke, and allele-sharing
methods. In any linkage or association study that uses
multipoint marker analysis, a correct marker order and
precise intermarker distances are important. Otherwise,
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Figure 4 Genetic, physical, and combined maps for STRK1, on 5q, from D5S1968 to D5S2046. Markers assigned in both the genetic
map and the physical map are displayed in black, markers derived only from physical-map information are displayed in red, and markers
derived only from genetic-map information are displayed in blue. Marker distances (in cM) in the combined map were constructed by applying
the estimation-maximization algorithm to the final marker order; marker distances (in Mb) in the physical map are estimations from the FPC
program.
the apparent increase in information content is neutralized
or reduced by the resultingmisinformation.We found that
a direct application of most public genetic and physical
maps, which may have numerous inaccuracies or ambi-
guities, have a negative impact on the LOD score of this
locus for stroke. While our work was in progress, an
assembly of the current draft of the human genome—
the University of California–Santa Cruz (UCSC) Human
Genome Project Working Draft—was made available
(Lander et al. 2001). This assembly merges together
Gretarsdottir et al.: Stroke Maps to 5q12 601
Figure 5 Linkage analyses with marker orders from our combined map (A; see fig. 4) and maps from Ge´ne´thon (B), the Center for
Medical Genetics, Marshfield Medical Research Foundation (C; where the Marshfield map has no resolution, our order was used), Stanford
(D; radiation-hybrid map), the Weizman Institute Unified Database for Human Genome Mapping (E), Whitehead Institute Center for Genome
Research (since the Whitehead map only gives order and not distances, it was run both with distances based on application of the estimation-
maximization algorithm [F] and with equally spaced markers [G]).
overlapping fragments and orders and orients nonover-
lapping fragments on the basis of mRNA, EST, paired
plasmid reads, and other information. In the April 2001
freeze from UCSC (for which data was released in June
2001), 30 of our 31 linkage markers mapped to two
contigs (the remaining marker was not mapped in this
freeze). The marker order within the contigs was in
agreement with our order, with the exception of two
markers, D5S2858 and D5S668. However, in the latest
release, in October 2001 (August 2001 freeze), several
changes have occurred. Whereas the order of the two
markers (D5S2858 and D5S668) has been changed and
is now consistent with our order, two other pieces—
one involving D5S2028–D5S2080 (11 Mb) and the
other involving D5S427 and D5S1956 (∼200 kb)—are
flipped and thus are inconsistent with what we believe
to be the correct order. This indicates that there is still
substantial uncertainty in the assembly of the public
human sequence.
The types of stroke that are presented in this article
do not reflect a rare stroke form or a form specific to
Iceland. Rather, the diverse stroke phenotypes in Ice-
landers, as well as known risk factors for stroke, are
similar to those of most other white populations (Svein-
bjo¨rnsdottir et al. 1998; Valdimarsson et al. 1998; Elias-
son et al. 1999).
The known genetic factors contributing to common
stroke may act indirectly, by increasing the risk of some
predisposing conditions, such as diabetes, hyperlipide-
mias, and/or hypertension. It is also possible that there
are genetic factors for stroke that do not influence sus-
ceptibilities to the known risk factors, as has been sug-
gested by epidemiological studies for myocardial in-
farction (Shea et al. 1984; Friedlander et al. 1985;
Myers et al. 1990). Epidemiological studies of the com-
mon forms of stroke have given conflicting results in
regard to the role of family history. Some studies have
shown that parental history predicts the risk of stroke
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Table 2
Prevalence of Risk Factors
RISK FACTOR
% [NO.] AFFECTED AMONG
All Patients
( )np 453
Patients in Families
with NPL 11
( )np 117
Hypertensiona 73 [329] 76 [89]
Diabetesb 14 [63] 15 [18]
Hypercholesterolemiac 24 [111] 21 [25]
NOTE.—For 23 patients, information on risk factors was
unavailable.
a If patients (a) had measured blood-pressure values of SBP 160
mmHg and/or DBP 95 mmHg, (b) had a history of hypertension,
or (c) had no history of hypertension but were being treated for
hypertension.
b If patients (a) had nonfasting glucose levels 10 mM, (b) had a
history of diabetes, or (c) had no history but were being treated for
diabetes.
c If patients (a) had total cholesterol 7 mM or (b) were on lipid-
lowering medication.
independently from conventional risk factors (Jousilahti
et al. 1997; Liao et al. 1997), whereas others have failed
to find evidence for such independent factors (Kiely et
al. 1993; Lindenstrom et al. 1993; Graffagnino 1994).
However, our work describes the first reported genome
scan in search of genes that contribute to common forms
of stroke. Our data suggest that the locus we have
mapped contributes directly to stroke, rather than in-
directly through known risk factors for stroke. This sug-
gests that there may be biological pathways independent
of the known risk factors that contribute to the path-
ogenesis of stroke. Regardless of what the mechanism
is, the evidence presented supports a major genetic com-
ponent in the pathogenesis of stroke in Iceland.
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